(Q33826713)

29 July 2017

title

The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China (English)

1 reference

triple-negative breast cancer

29 July 2017

0 references

1 reference

Yong Tao Li

1

1 reference

29 July 2017

Duo Ni

2

1 reference

29 July 2017

Liang Yang

3

1 reference

29 July 2017

Qian Zhao

4

1 reference

29 July 2017

Jiang Hua Ou

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

25 June 2014

1 reference

European Journal of Medical Research

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

page(s)

35

1 reference

Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Triple-Negative Breast Cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Triple-negative breast cancer: clinical features and patterns of recurrence

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

BRCA1 and BRCA2: 1994 and beyond

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Risk reducing mastectomy: outcomes in 10 European centres.

4 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2047-783X-19-35

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2047-783X-19-35

Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076498

29 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961674

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24961674

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expanding the Criteria forBRCAMutation Testing in Breast Cancer Survivors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24961674

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/2047-783X-19-35

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference